Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN

FKD3DUK39I

Status:

Possibly Marketed Outside US

Source:

BLA125296

(2011)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7d0b43c-7250-4809-8a05-fcde5862f076

First approved in 2011

Source:

BLA125296

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7d0b43c-7250-4809-8a05-fcde5862f076

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1